Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Drugmaker GSK profit rockets on consumer health spinoff
Drugmaker GSK profit rockets on consumer health spinoff
Agence France-Presse
Published Nov 02, 2022 04:38 PM PHT
The vaccines production center of GlaxoSmithKline (GSK) in Wavre, Belgium, 03 February 2021. GSK announced earlier today it will support CureVac in the manufacture of up to 100 million doses at its Wavre production site. EPA-EFE/OLIVIER HOSLET
LONDON - British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rocketed almost ten-fold to £10.3 billion ($11.5 billion) on the blockbuster spinoff of consumer healthcare division Haleon.
Earnings after taxation spiked in the three months to the end of September from a year earlier, due to a total gain of £9.6 billion on the Haleon demerger, GSK said in a results statement.
ABS-CBN is the leading media and entertainment company in the Philippines, offering quality content across TV, radio, digital, and film. Committed to public service and promoting Filipino values, ABS-CBN continues to inspire and connect audiences worldwide.
Our website is made possible by displaying online
advertisements to our visitors. Please consider supporting
us by disabling your ad blocker on our website.
Our website is made possible by displaying online
advertisements to our visitors. Please consider supporting
us by disabling your ad blocker on our website.
